financetom
Business
financetom
/
Business
/
BRIEF-Sony's Bid For Paramount Considered Serious By Special Committee- CNBC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Sony's Bid For Paramount Considered Serious By Special Committee- CNBC
May 3, 2024 6:42 AM

May 3 (Reuters) -

* SONY'S ( SONY ) BID FOR PARAMOUNT CONSIDERED SERIOUS BY SPECIAL

COMMITTEE- CNBC

* SKYDANCE'S EXCLUSIVITY PERIOD WITH PARAMOUNT WILL NOT BE

EXTENDED - CNBC

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bausch Health Q2 Adjusted Profit Declines, Revenue up 11%; Revenue Guidance Raised
Bausch Health Q2 Adjusted Profit Declines, Revenue up 11%; Revenue Guidance Raised
Aug 1, 2024
07:55 AM EDT, 08/01/2024 (MT Newswires) -- Bausch Health ( BHC ) on Thursday said adjusted profit and revenue rose in the second quarter. Adjusted profit of US$328 million compares with US$300 million last year. Bausch Health ( BHC ) reported total revenue increased 11% to US$2.4 billion. The company raised its full year revenue guidance to US$9.65 billion from...
US navy shipbuilder Huntington Ingalls beats second-quarter estimates
US navy shipbuilder Huntington Ingalls beats second-quarter estimates
Aug 1, 2024
(Reuters) - Huntington Ingalls on Thursday reported better-than-expected second-quarter results, as heightened global tensions drove up demand for aircraft carriers, amphibious assault ships and submarines. The Virginia-based company reported a profit of $4.38 per share for the quarter ended June 30, ahead of analysts' estimates of $3.62. Demand for submarines and aircraft carriers is surging, fueled by China's expanding naval...
Neurocrine Biosciences Q2 Adjusted Earnings, Revenue Climb -- Shares Up Pre-Bell
Neurocrine Biosciences Q2 Adjusted Earnings, Revenue Climb -- Shares Up Pre-Bell
Aug 1, 2024
08:14 AM EDT, 08/01/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) reported Q2 adjusted earnings Thursday of $1.63 per diluted share, up from $1.25 a year earlier. Analysts polled by Capital IQ expected $1.53. Revenue for the quarter ended June 30 was $590.2 million, up from $452.7 million a year earlier. Analysts polled by Capital IQ expected $546.5 million....
US proposes barring airlines from charging family seating fees
US proposes barring airlines from charging family seating fees
Aug 1, 2024
WASHINGTON, Aug 1 (Reuters) - The U.S. Department of Transportation said on Thursday it is proposing to bar U.S. and foreign airlines from charging fees to seat families with young children together on a flight if adjacent seats are available during booking. The Biden administration said in February 2023 it planned to write regulations barring the fees as officials pressured...
Copyright 2023-2026 - www.financetom.com All Rights Reserved